Clinical trial
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized…
NCT00019955 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019955 |
|---|---|
| Title | Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) |
| Official title | A Phase II Study to Evaluate Radiofrequency Ablation of Renal Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Procedure |
| Interventions | laparoscopic surgery, radiofrequency ablation, thermal ablation therapy |
| Start date | Mar 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: